The Cancer Letter

Inside information on cancer research and drug development

Vol.
20
No.
18
May 06, 1994May 06, 1994
Free
DOWNLOAD THE PDF

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

Fisher and Redmond Subject Of Misconduct Investigation; ORI

Herberman Outlines NSABP restructuring In Plan To NCI

DCT Advisors Approve Increased Spending On Trials Monitoring

Possible Breach of Patient Confidentially By Calif. Physician; NCI

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account